Heart News and Research

RSS

CVD risk among people with HIV varies by geography, income

People living with human immunodeficiency virus infection are at higher risk of cardiovascular disease compared to people without HIV.

1 Apr 2020

BU creates COVID-19 US state policy database to track steps taken to slow the pandemic

Researchers and students at the Boston University School of Public Health (BUSPH) have created a COVID-19 US state policy database, tracking steps that each U.S. state has taken to curb the spread of the new coronavirus and when those steps were implemented.

1 Apr 2020

NYU researchers capture 3D data on human interactions with COVID-19 infection sources

New York University researchers are in the field capturing highly detailed three-dimensional data on human movements and behaviors -- particularly around medical facilities, public transportation systems, and essential services -- to document the complex landscape of "surface vectors" and thus opportunities for COVID-19 transmission.

1 Apr 2020

Scientists work on early alert system for COVID-19

To better understand early signs of coronavirus and the virus' spread, physicians around the country and data scientists at UC San Diego are working together to use a wearable device to monitor more than 12,000 people, including thousands of healthcare workers.

1 Apr 2020

CVIA publishes new issue that brings key research papers from top cardiologists

The journal Cardiovascular Innovations and Applications (CVIA) has just published a new issue, Volume 4 Issue 3 with an invitation to join the International Brugada Electrocardiographic Indices Registry.

1 Apr 2020

New brain-imaging study sheds light on human creativity

According to a popular view, creativity is a product of the brain's right hemisphere – innovative people are considered "right-brain thinkers" while "left-brain thinkers" are thought to be analytical and logical.

1 Apr 2020

Antihypertensive drugs may protect against COVID-19 in heart patients

Common drugs used in high blood pressure, heart failure, and diabetic patients with kidney damage, including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), could be protective in patients with COVID-19.

31 Mar 2020

FDA to trial malaria drugs Chloroquine and Hydroxychloroquine for COVID-19

The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.

31 Mar 2020

Three Australian experts explain the course of COVID-19

Researchers have been studying the ongoing pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) closely since its beginning in December 2019. To date, the virus has infected over 850,000 individuals across the globe and killed over 41,000.

31 Mar 2020

Mobile health devices effective in reducing AF-related adverse events, study finds

A new study, published in the Journal of the American College of Cardiology, highlights the feasible use of mobile health (mHealth) devices to help with the screening and detection of a common heart condition.

31 Mar 2020

People working long hours more likely to have hypothyroidism

Adults who work long hours are more likely to have hypothyroidism, which is an underactive thyroid, according to study results accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.

31 Mar 2020

Two newer types of diabetes medications show heart and kidney benefits

Two newer types of medications commonly used to treat type 2 diabetes are similar in their ability to reduce major heart complications, including heart attack, stroke and death from cardiovascular disease, according to research accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.

31 Mar 2020

Machine learning can help predict future diabetes patients

A type of artificial intelligence called machine learning can help predict which patients will develop diabetes, according to an ENDO 2020 abstract that will be published in a special supplemental section of the Journal of the Endocrine Society.

31 Mar 2020

Sheltered at home, families broach end-of-life planning

Long before she contracted COVID-19 at a Kirkland, Washington, nursing home, Barbara Dreyfuss made sure to document the wishes that would govern how she died.

31 Mar 2020

New 3D bioprinting technologies to create cardiovascular tissue

Cardiovascular disease is the leading cause of death worldwide, with over 17 million per year according to the World Health Organization.

From IDTechEx Ltd 31 Mar 2020

Horizon Discovery and Pharmahungary report positive early-stage results for novel micro-RNA therapeutic for ischemic heart diseases

Horizon Discovery Group plc and Pharmahungary Group announced positive early-stage results for a novel micro-RNA therapeutic for ischemic heart diseases.

31 Mar 2020

Working too many hours may lead to an underactive thyroid

A new study has found that people who work longer hours are more likely to have an underactive thyroid or hypothyroidism.

31 Mar 2020

Should you bring mom home from assisted living during the pandemic?

Dr. Alison Webb took her 81-year-old father out of assisted living, to live.

31 Mar 2020

Evinacumab drug reduces cholesterol levels in patients with rare cholesterol disorder

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled trial of the drug, which is being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

31 Mar 2020

Ticagrelor therapy, without aspirin, can benefit patients with acute coronary syndrome

Patients with acute coronary syndrome (ACS) who stopped taking aspirin three months after the insertion of a coronary stent and then took the anti-platelet medication ticagrelor alone for nine months had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor for a year.

31 Mar 2020